What the Company Names on a Drug Carton Actually Tell You

Answer first: an unqualified name claims everything

Federal regulation treats a company name on a drug package as a statement, not decoration. Where a name appears with no qualifying phrase, the regulation says that is a representation that the named person is the sole manufacturer of the product.

It then says what happens if that is untrue. The representation is false and misleading, and the product is misbranded, if the named person is not the manufacturer as the regulation defines the word.

The practical reading is short. A bare name claims the whole job. A name with a phrase in front of it is admitting that somebody else did part of it.

That is why the small print above a company name is the most informative text on the outside of a medication package.

The statute the rule sits on

The requirement itself is old and plain. A drug in package form is misbranded unless it bears a label containing the name and place of business of the manufacturer, packer, or distributor, along with an accurate statement of the quantity of contents.

A second provision runs alongside it. A drug is misbranded if its labeling is false or misleading in any particular, which is the hook the naming rule uses when a name overstates what a firm did.

The regulation restates both. A drug or drug product in finished package form is misbranded if its label does not bear conspicuously the name and place of business of the manufacturer, packer, or distributor.

One limit sits in that same paragraph and is easy to skim past. It says the paragraph does not apply to a drug or drug product dispensed in accordance with the prescription-dispensing provision of the Act, which is a different document with a different rule behind it.

What manufacturer means here, and it is a list of jobs

The regulation does not leave the word to ordinary usage. For this purpose the manufacturer is the person who performs all of the listed operations that are required to produce the product.

The list is concrete. It covers mixing, granulating, milling, molding, lyophilizing, tableting, encapsulating, coating, sterilizing, and filling sterile or aerosol drugs into dispensing containers, with a separate clause for medical gases.

There is also a test for whether a firm really performed one of those steps. The work has to be done by individuals a majority of whom are its employees, subject to its direction and control. It also has to happen on premises the firm continuously owns or leases, using equipment it continuously owns or leases.

So the title is earned by doing the work with your own people, in your own building, on your own machines. Buying the result does not qualify.

When nobody does all of it, and most of the time nobody does

Modern drug production is split between firms, and the regulation accounts for that. If no person performs all of the applicable operations, no person may be represented as manufacturer except in four described ways.

The first is a blanket acknowledgment. A firm performing more than half of the applicable operations may be named, provided the label states that certain manufacturing operations have been performed by other firms.

The second names the split. A firm performing at least one operation may be named if it identifies all the others by appropriate designation. The regulation's own example reads made by one person, filled by a second, sterilized by a third.

The third is a joint listing, qualified by a jointly manufactured phrase, with all names printed together in the same type size and style. The fourth covers a firm that does everything except operations the agency has found are commonly contracted out.

That last category is named in the regulation. It lists soft-gelatin encapsulating, aerosol filling, sterilizing by irradiation, lyophilizing, and ethylene oxide sterilization as the common contracted steps.

Six phrases that mark a distributor, and two that mark a packer

Where a distributor is named on a label, the regulation requires a qualifying phrase and supplies the permitted wording. The options are manufactured for, distributed by, manufactured by one firm for another, manufactured for one firm by another, distributor, and marketed by.

A packer gets its own pair. If the packer is identified, the name has to be qualified by packed by or packaged by.

The regulation allows all of these to be abbreviated, which is why they often appear compressed into a line of tiny type. They are still doing the same work.

This is the single most useful reading habit on a medication package. If the name at the bottom is preceded by one of those phrases, the firm is telling you it is not the maker.

The name that made nothing at all

There is a defined role for a company whose only contribution is its brand. A private label distributor is a person who did not manufacture, repack, relabel, or salvage the drug, but under whose label or trade name the drug is commercially distributed.

That is a legitimate arrangement with a name, not a trick. It is worth knowing because it explains how the front of a package and the back of it can point at different companies without anything being wrong.

The regulation also permits a related piece of information. Where two or more names appear, the label may identify which of them to contact for further information about the product.

And where a trademark appears, the label may identify the holder or the licensee of that trademark, and may state which of the two the named firm is.

The address is not necessarily the plant

The place of business has a specified content. It includes the street address, city, state and postal code, and for a foreign manufacturer the street address, city, country and any applicable mailing code.

One allowance shortens it. The street address may be omitted if it appears in a current city directory or telephone directory, which is a rule written for a filing cabinet era and still on the books.

A second allowance moves it. Where a firm manufactures, packs or distributes at a place other than its principal place of business, the label may state the principal place of business instead, unless doing so would be misleading.

So an address on a carton answers where to write, not necessarily where the work happened. That is a meaningful gap when someone is trying to learn where a medication came from.

Three limits worth reading to the end for

The naming rule has boundaries that its own text states, and skipping them produces confident errors. The first is the exclusion already mentioned for a drug dispensed under the prescription-dispensing provision.

The second concerns ingredients rather than products. Several of the manufacturer-definition paragraphs do not apply to the labeling of drug components at all.

The third is a whole category. The section states that it does not apply to biological drug products that are subject to the licensing provision of the Public Health Service Act.

There is also a rule about the name itself. For a corporation the requirement is satisfied only by the actual corporate name. That name may be that of a parent, subsidiary or affiliate under common ownership and control, and words such as company or incorporated may be abbreviated or omitted.

Where a compounded product parts company with all of this

The rules above describe the packaging of a manufactured product. A compounded preparation is not produced under an approved application, and the questions a buyer can ask about it change shape accordingly.

FDA has spoken to that market directly. In its reminders to telehealth companies it names branding that falsely or misleadingly implies the telehealth company is the compounder as a claim not to make.

The same reminders address a related sentence. Claiming a compounded drug is sourced from an approved or licensed pharmacy or outsourcing facility is on the agency's list, and the reason it gives is that FDA does not approve or license any facility.

Put beside the naming regulation, both make the same point from different directions. A company's presence on a package or a website describes a commercial relationship, and only the qualifying language tells you which one.

What this makes askable

Turn the front of the package over and read the smallest line of type. Note whether any name carries a qualifying phrase, and note which phrase it is.

Then ask the program a question it can answer in one sentence. Which company holds the approval for the product, and which facility physically produced the container that arrived.

If the answer names only a brand, the naming regulation is the reason that is not yet an answer. A brand may be a distributor, a private label distributor, a trademark licensee, or the maker.

None of that decides whether a product is good. It decides whether you have been told who is behind it, which is a separate and checkable thing.